Summary
A single dose of 60 mg trimetazidine (the normal daily dose) improved exercise capacity in angina pectoris, as reflected by an increase in the duration of exercise, total work performed, and improvement in ECG signs of ischaemia. All these effects occurred without any detectable chronotropic or vasomotor effect. The importance of this study is to demonstrate that these beneficial effects, already well-recognized after chronic administration of 20 mg three times a day, also occur after a single administration equivalent to the normal daily dose.
This is a preview of subscription content, log in via an institution to check access.
References
Roulet MJ, Garnier D (1985) Vasoactivity of trimetazidine on guinea-pig isolated ductus arteriosus. Br J Pharmacol 84: 517–524
Honoré E, Adamantidis MM, Challice CE, Dupuis BA (1986) Cardioprotection by calcium antagonists, piridoxilate and trimetazidine. IRCS Med Sci 14: 938–939
Maridonneau-Parini I, Harpey C (1985) Effect of trimetazidine on menbrane damage induced by oxygen free radicals in human red cells. Br J Clin Pharmacol 20: 148–151
Canicave JC (1980) Détermination en simple insu contre placebo de la relation dose/activité de Vastarel 20 mg dans l'insuffisance coronarienne chronique. Gaz Méd Fr 87: 5560–5563
Sellier P (1986) Effets de la trimétazidine sur les paramètres ergométriques dans l'angor d'effort — Etude multicentrique contôlée à double insu contre placebo. Arch Mal Coeur 9: 1331–1336
Sellier P, Maurice P (1987) Recherche des effets hémodynamiques de la trimétazidine en administration chez l'homme. Therapie 42: 245–246
Author information
Authors and Affiliations
Additional information
Vastarel 20 mg. Laboratoires Biopharmaceutiques de France
Rights and permissions
About this article
Cite this article
Sellier, P., Audouin, P., Payen, B. et al. Acute effects of trimetazidine evaluated by exercise testing. Eur J Clin Pharmacol 33, 205–207 (1987). https://doi.org/10.1007/BF00544569
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00544569